Authors:
KATABIRA ET
SEWANKAMBO NK
MUGERWA RD
BELSEY EM
MUBIRU FX
OTHIENO C
KATAAHA P
KARAM M
YOULE M
PERRIENS JH
LANGE JMA
Citation: Et. Katabira et al., LACK OF EFFICACY OF LOW-DOSE ORAL INTERFERON-ALPHA IN SYMPTOMATIC HIV-1 INFECTION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, SEXUALLY TRANSMITTED INFECTIONS, 74(4), 1998, pp. 265-270
Citation: J. Veenstra et Jma. Lange, CUTANEOUS ADVERSE REACTIONS AND CD4(-INFECTED PATIENTS RECEIVING TRIMETHOPRIM-SULFAMETHOXAZOLE - REPLY() CELL COUNTS IN HUMAN IMMUNODEFICIENCY VIRUS), Clinical infectious diseases, 26(2), 1998, pp. 531-532
Authors:
HOETELMANS RMW
VANHEESWIJK RPG
PROFIJT M
MULDER JW
MEENHORST PL
LANGE JMA
REISS P
BEIJNEN JH
Citation: Rmw. Hoetelmans et al., COMPARISON OF THE PLASMA PHARMACOKINETICS AND RENAL CLEARANCE OF DIDANOSINE DURING ONCE AND TWICE-DAILY DOSING IN HIV-1-INFECTED INDIVIDUALS, AIDS, 12(17), 1998, pp. 211-216
Authors:
FOUDRAINE NA
DEJONG JJ
WEVERLING GJ
VANBENTHEM BHB
MAAS J
KEET IPM
JURRIAANS S
ROOS MTL
VANDERMEULEN K
DEWOLF F
LANGE JMA
Citation: Na. Foudraine et al., AN OPEN RANDOMIZED CONTROLLED TRIAL OF ZIDOVUDINE PLUS LAMIVUDINE VERSUS STAVUDINE PLUS LAMIVUDINE, AIDS, 12(12), 1998, pp. 1513-1519
Authors:
HOETELMANS RMW
REIJERS MHE
WEVERLING GJ
TENKATE RW
WIT FWNM
MULDER JW
WEIGEL HM
FRISSEN PHJ
ROOS M
JURRIAANS S
SCHUITEMAKER H
DEWOLF F
BEIJNEN JH
LANGE JMA
Citation: Rmw. Hoetelmans et al., THE EFFECT OF PLASMA DRUG CONCENTRATIONS ON HIV-1 CLEARANCE RATE DURING QUADRUPLE DRUG-THERAPY, AIDS, 12(11), 1998, pp. 111-115
Authors:
WEVERLING GJ
LANGE JMA
JURRIAANS S
PRINS JM
LUKASHOV VV
NOTERMANS DW
ROOS M
SCHUITEMAKER H
HOETELMANS RMW
DANNER SA
GOUDSMIT J
DEWOLF F
Citation: Gj. Weverling et al., ALTERNATIVE MULTIDRUG REGIMEN PROVIDES IMPROVED SUPPRESSION OF HIV-1 REPLICATION OVER TRIPLE THERAPY, AIDS, 12(11), 1998, pp. 117-122
Authors:
FOUDRAINE NA
WEVERLING GJ
VANGOOL T
ROOS MTL
DEWOLF F
KOOPMANS PP
VANDENBROEK PJ
MEENHORST PL
VANLEEUWEN R
LANGE JMA
REISS P
Citation: Na. Foudraine et al., IMPROVEMENT OF CHRONIC DIARRHEA IN PATIENTS WITH ADVANCED HIV-1 INFECTION DURING POTENT ANTIRETROVIRAL THERAPY, AIDS, 12(1), 1998, pp. 35-41
Authors:
DEJONG MD
BOUCHER CAB
DANNER SA
GAZZARD B
GRIFFITHS PD
KATLAMA C
LANGE JMA
RICHMAN DD
VELLA S
Citation: Md. Dejong et al., SUMMARY OF THE INTERNATIONAL CONSENSUS SYMPOSIUM ON MANAGEMENT OF HIV, CMV AND HEPATITIS-VIRUS INFECTIONS, Antiviral research, 37(1), 1998, pp. 1-16
Authors:
REIJERS MHE
WEVERLING GJ
JURRIAANS S
WIT FWNM
WEIGEL HM
TENKATE RW
MULDER JW
FRISSEN PHJ
VANLEEUWEN R
REISS P
SCHUITEMAKER H
DEWOLF F
LANGE JMA
Citation: Mhe. Reijers et al., MAINTENANCE THERAPY AFTER QUADRUPLE INDUCTION THERAPY IN HIV-1-INFECTED INDIVIDUALS - AMSTERDAM DURATION OF ANTIRETROVIRAL MEDICATION (ADAM) STUDY, Lancet, 352(9123), 1998, pp. 185-190
Authors:
FOUDRAINE NA
HOETELMANS RMW
LANGE JMA
DEWOLF F
VANBENTHEM BHB
MASS JJ
KEET IPM
PORTEGIES P
Citation: Na. Foudraine et al., CEREBROSPINAL-FLUID HIV-1 RNA AND DRUG CONCENTRATIONS AFTER TREATMENTWITH LAMIVUDINE PLUS ZIDOVUDINE OR STAVUDINE, Lancet, 351(9115), 1998, pp. 1547-1551
Authors:
MONTANER JSG
REISS P
COOPER D
VELLA S
HARRIS M
CONWAY B
WAINBERG MA
SMITH D
ROBINSON P
HALL D
MYERS M
LANGE JMA
Citation: Jsg. Montaner et al., A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING COMBINATIONS OF NEVIRAPINE, DIDANOSINE, AND ZIDOVUDINE FOR HIV-INFECTED PATIENTS - THE INCAS TRIAL, JAMA, the journal of the American Medical Association, 279(12), 1998, pp. 930-937
Authors:
PAKKER NG
ROOS MTL
VANLEEUWEN R
DEJONG MD
KOOT M
REISS P
LANGE JMA
MIEDEMA F
DANNER SA
SCHELLEKENS PTA
Citation: Ng. Pakker et al., PATTERNS OF T-CELL REPOPULATION, VIRUS LOAD REDUCTION, AND RESTORATION OF T-CELL FUNCTION IN HIV-INFECTED PERSONS DURING THERAPY WITH DIFFERENT ANTIRETROVIRAL AGENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 16(5), 1997, pp. 318-326
Authors:
VEENSTRA J
VEUGELERS PJ
KEET IPM
VANDERVEN AJAM
MIEDEMA F
LANGE JMA
COUTINHO RA
Citation: J. Veenstra et al., RAPID DISEASE PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED INDIVIDUALS WITH ADVERSE REACTIONS TO TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS, Clinical infectious diseases, 24(5), 1997, pp. 936-941
Authors:
DEJONG MD
BOUCHER CAB
COOPER DA
GALASSO GJ
GAZZARD B
LANGE JMA
MONTANER JS
RICHMAN DD
THOMAS HC
Citation: Md. Dejong et al., SUMMARY OF THE 2ND INTERNATIONAL CONSENSUS SYMPOSIUM ON COMBINED ANTIVIRAL THERAPY AND IMPLICATIONS FOR FUTURE THERAPIES, Antiviral research, 35(2), 1997, pp. 65-82
Authors:
FRISSEN PHJ
DEWOLF F
REISS P
BAKKER PJM
VEENHOF CHN
DANNER SA
GOUDSMIT J
LANGE JMA
Citation: Phj. Frissen et al., HIGH-DOSE INTERFERON-ALPHA-2A EXERTS POTENT ACTIVITY AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NOT ASSOCIATED WITH ANTITUMOR-ACTIVITY IN SUBJECTS WITH KAPOSIS-SARCOMA, The Journal of infectious diseases, 176(3), 1997, pp. 811-814
Authors:
VANLEEUWEN R
BONSEL GJ
REISS P
DANNER SA
LANGE JMA
Citation: R. Vanleeuwen et al., ADDITIVE OR SEQUENTIAL NUCLEOSIDE ANALOG THERAPY COMPARED WITH CONTINUED ZIDOVUDINE MONOTHERAPY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH ADVANCED DISEASE DOES NOT PROLONG SURVIVAL - AN OBSERVATIONAL STUDY, The Journal of infectious diseases, 175(6), 1997, pp. 1344-1351
Authors:
DEJONG MD
VELLA S
CARR A
BOUCHER CAB
IMRIE A
FRENCH M
HOY J
SORICE S
PAULUZZI S
CHIODO F
WEVERLING GJ
VANDERENDE ME
FRISSEN PJ
WEIGEL HM
KAUFFMANN RH
LANGE JMA
YOON R
MORONI M
HOENDERDOS E
LEITZ G
COOPER DA
HALL D
REISS P
Citation: Md. Dejong et al., HIGH-DOSE NEVIRAPINE IN PREVIOUSLY UNTREATED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS DOES NOT RESULT IN SUSTAINED SUPPRESSION OF VIRAL REPLICATION, The Journal of infectious diseases, 175(4), 1997, pp. 966-970
Authors:
VANTWOUT AB
RAN LJ
DEJONG MD
BAKKER M
VANLEEUWEN R
NOTERMANS DW
LOELIGER AE
DEWOLF F
DANNER SA
REISS P
BOUCHER CAB
LANGE JMA
SCHUITEMAKER H
Citation: Ab. Vantwout et al., SELECTIVE-INHIBITION OF SYNCYTIUM-INDUCING AND NONSYNCYTIUM-INDUCING HIV-1 VARIANTS IN INDIVIDUALS RECEIVING DIDANOSINE OR ZIDOVUDINE, RESPECTIVELY, The Journal of clinical investigation, 100(9), 1997, pp. 2325-2332